coagulation
FDA Approves Balfaxar for Warfarin Reversal
The FDA approved Balfaxar to reverse acquired coagulation factor deficiency by vitamin K antagonists in adults who ...
JULY 27, 2023
FDA Expands Pediatric Labeling for Fibryga; Updates Research in Label for Octaplas
The FDA approved Octapharma supplements to two Biological License Applications, including an expanded indication ...
MARCH 29, 2021
Load more